2022 Q1 Form 10-Q Financial Statement
#000147793222003236 Filed on May 12, 2022
Income Statement
| Concept | 2022 Q1 | 2021 Q1 |
|---|---|---|
| Revenue | $0.00 | $0.00 |
| YoY Change | ||
| Cost Of Revenue | ||
| YoY Change | ||
| Gross Profit | ||
| YoY Change | ||
| Gross Profit Margin | ||
| Selling, General & Admin | $1.914M | $1.780M |
| YoY Change | 7.5% | -8.25% |
| % of Gross Profit | ||
| Research & Development | $262.8K | $369.5K |
| YoY Change | -28.86% | -5.27% |
| % of Gross Profit | ||
| Depreciation & Amortization | ||
| YoY Change | ||
| % of Gross Profit | ||
| Operating Expenses | $2.176M | $2.152M |
| YoY Change | 1.12% | -7.63% |
| Operating Profit | -$2.053M | -$2.049M |
| YoY Change | 0.2% | |
| Interest Expense | $3.510K | $40.00K |
| YoY Change | -91.23% | -33.33% |
| % of Operating Profit | ||
| Other Income/Expense, Net | $123.4K | $103.3K |
| YoY Change | 19.39% | |
| Pretax Income | -$2.050M | -$2.012M |
| YoY Change | 1.87% | -10.97% |
| Income Tax | $0.00 | $0.00 |
| % Of Pretax Income | ||
| Net Earnings | -$2.050M | -$2.012M |
| YoY Change | 1.87% | -11.13% |
| Net Earnings / Revenue | ||
| Basic Earnings Per Share | -$0.20 | -$0.33 |
| Diluted Earnings Per Share | -$0.20 | -$0.33 |
| COMMON SHARES | ||
| Basic Shares Outstanding | 10.28M shares | 6.589M shares |
| Diluted Shares Outstanding |
Balance Sheet
| Concept | 2022 Q1 | 2021 Q1 |
|---|---|---|
| SHORT-TERM ASSETS | ||
| Cash & Short-Term Investments | $28.23M | $15.24M |
| YoY Change | 85.22% | -6.67% |
| Cash & Equivalents | $28.23M | $15.24M |
| Short-Term Investments | ||
| Other Short-Term Assets | $558.8K | $640.0K |
| YoY Change | -12.69% | 88.24% |
| Inventory | ||
| Prepaid Expenses | ||
| Receivables | ||
| Other Receivables | ||
| Total Short-Term Assets | $28.79M | $15.87M |
| YoY Change | 81.38% | -4.86% |
| LONG-TERM ASSETS | ||
| Property, Plant & Equipment | ||
| YoY Change | ||
| Goodwill | ||
| YoY Change | ||
| Intangibles | $100.0K | |
| YoY Change | ||
| Long-Term Investments | ||
| YoY Change | ||
| Other Assets | ||
| YoY Change | ||
| Total Long-Term Assets | $101.6K | $90.00K |
| YoY Change | 12.87% | -95.0% |
| TOTAL ASSETS | ||
| Total Short-Term Assets | $28.79M | $15.87M |
| Total Long-Term Assets | $101.6K | $90.00K |
| Total Assets | $28.89M | $15.96M |
| YoY Change | 81.0% | -13.64% |
| SHORT-TERM LIABILITIES | ||
| YoY Change | ||
| Accounts Payable | $100.0K | $180.0K |
| YoY Change | -44.44% | 80.0% |
| Accrued Expenses | $100.0K | $450.0K |
| YoY Change | -77.78% | 12.5% |
| Deferred Revenue | ||
| YoY Change | ||
| Short-Term Debt | $0.00 | $0.00 |
| YoY Change | ||
| Long-Term Debt Due | ||
| YoY Change | ||
| Total Short-Term Liabilities | $452.8K | $630.0K |
| YoY Change | -28.12% | 28.57% |
| LONG-TERM LIABILITIES | ||
| Long-Term Debt | $0.00 | $0.00 |
| YoY Change | ||
| Other Long-Term Liabilities | ||
| YoY Change | ||
| Total Long-Term Liabilities | $0.00 | $0.00 |
| YoY Change | ||
| TOTAL LIABILITIES | ||
| Total Short-Term Liabilities | $452.8K | $630.0K |
| Total Long-Term Liabilities | $0.00 | $0.00 |
| Total Liabilities | $452.8K | $630.0K |
| YoY Change | -28.12% | 28.57% |
| SHAREHOLDERS EQUITY | ||
| Retained Earnings | ||
| YoY Change | ||
| Common Stock | ||
| YoY Change | ||
| Preferred Stock | ||
| YoY Change | ||
| Treasury Stock (at cost) | ||
| YoY Change | ||
| Treasury Stock Shares | ||
| Shareholders Equity | $28.43M | $15.33M |
| YoY Change | ||
| Total Liabilities & Shareholders Equity | $28.89M | $15.96M |
| YoY Change | 81.0% | -13.64% |
Cashflow Statement
| Concept | 2022 Q1 | 2021 Q1 |
|---|---|---|
| OPERATING ACTIVITIES | ||
| Net Income | -$2.050M | -$2.012M |
| YoY Change | 1.87% | -11.13% |
| Depreciation, Depletion And Amortization | ||
| YoY Change | ||
| Cash From Operating Activities | -$1.934M | -$6.296M |
| YoY Change | -69.29% | 211.66% |
| INVESTING ACTIVITIES | ||
| Capital Expenditures | $0.00 | |
| YoY Change | ||
| Acquisitions | ||
| YoY Change | ||
| Other Investing Activities | $0.00 | |
| YoY Change | ||
| Cash From Investing Activities | $0.00 | $0.00 |
| YoY Change | ||
| FINANCING ACTIVITIES | ||
| Cash Dividend Paid | ||
| YoY Change | ||
| Common Stock Issuance & Retirement, Net | $5.413M | $0.00 |
| YoY Change | ||
| Debt Paid & Issued, Net | ||
| YoY Change | ||
| Cash From Financing Activities | $5.413M | $0.00 |
| YoY Change | -100.0% | |
| NET CHANGE | ||
| Cash From Operating Activities | -$1.934M | -$6.296M |
| Cash From Investing Activities | $0.00 | $0.00 |
| Cash From Financing Activities | $5.413M | $0.00 |
| Net Change In Cash | $3.479M | -$6.296M |
| YoY Change | -155.27% | 288.61% |
| FREE CASH FLOW | ||
| Cash From Operating Activities | -$1.934M | -$6.296M |
| Capital Expenditures | $0.00 | |
| Free Cash Flow | -$6.296M | |
| YoY Change | 211.66% |
Facts In Submission
| Frame | Concept Type | Concept / XBRL Key | Value | Unit |
|---|---|---|---|---|
| CY2022Q2 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
10590470 | shares |
| CY2022Q1 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
0 | USD |
| CY2022Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
0 | USD |
| CY2021Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
0 | USD |
| CY2022Q1 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
10588674 | shares |
| CY2021Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
9759223 | shares |
| CY2021Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-2011988 | USD |
| CY2022Q1 | us-gaap |
Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
|
0 | USD |
| CY2022Q1 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
-2049529 | USD |
| CY2021Q1 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
-2011988 | USD |
| CY2021Q1 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
-2200911 | USD |
| CY2022Q1 | us-gaap |
Revenues
Revenues
|
0 | USD |
| CY2021Q1 | us-gaap |
Revenues
Revenues
|
0 | USD |
| CY2021Q1 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
1782860 | USD |
| CY2022Q1 | ltbr |
Contributed Services Research And Development
ContributedServicesResearchAndDevelopment
|
123353 | USD |
| CY2022Q1 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
123353 | USD |
| CY2021Q1 | us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
103319 | USD |
| CY2022Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-2053034 | USD |
| CY2021Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-2048991 | USD |
| CY2022Q1 | us-gaap |
Interest Income Expense Net
InterestIncomeExpenseNet
|
3505 | USD |
| CY2021Q1 | us-gaap |
Interest Income Expense Net
InterestIncomeExpenseNet
|
3309 | USD |
| CY2022Q1 | ltbr |
Foreign Currency Transaction Gain
ForeignCurrencyTransactionGain
|
0 | USD |
| CY2021Q1 | ltbr |
Foreign Currency Transaction Gain
ForeignCurrencyTransactionGain
|
33694 | USD |
| CY2022Q1 | us-gaap |
Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
|
3505 | USD |
| CY2021Q1 | us-gaap |
Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
|
37003 | USD |
| CY2021Q1 | us-gaap |
Preferred Stock Dividends And Other Adjustments
PreferredStockDividendsAndOtherAdjustments
|
-131434 | USD |
| CY2022Q1 | us-gaap |
Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
|
0 | USD |
| CY2021Q1 | us-gaap |
Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
|
57489 | USD |
| CY2021Q1 | ltbr |
Earnings Per Share Basic And Diluted1
EarningsPerShareBasicAndDiluted1
|
-0.33 | |
| CY2022Q1 | ltbr |
Weighted Average Number Of Share Outstanding Basic And Diluted1
WeightedAverageNumberOfShareOutstandingBasicAndDiluted1
|
10283280 | shares |
| CY2021Q1 | ltbr |
Weighted Average Number Of Share Outstanding Basic And Diluted1
WeightedAverageNumberOfShareOutstandingBasicAndDiluted1
|
6589392 | shares |
| CY2022Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-2049529 | USD |
| CY2021Q1 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
60068 | USD |
| CY2022Q1 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
296305 | USD |
| CY2022Q1 | ltbr |
Increase Decrease In Accrued Legal Settlement Costs
IncreaseDecreaseInAccruedLegalSettlementCosts
|
0 | USD |
| CY2022Q1 | us-gaap |
Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
|
15000 | USD |
| CY2021Q1 | ltbr |
Increase Decrease In Accrued Legal Settlement Costs
IncreaseDecreaseInAccruedLegalSettlementCosts
|
4200000 | USD |
| CY2022Q1 | ltbr |
Shares Issued Registered Offerings Net Of Offering Costs Amount
SharesIssuedRegisteredOfferingsNetOfOfferingCostsAmount
|
5412863 | USD |
| CY2021Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-6295514 | USD |
| CY2022Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
0 | USD |
| CY2021Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
0 | USD |
| CY2022Q1 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
5412863 | USD |
| CY2021Q1 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
0 | USD |
| CY2022Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
5412863 | USD |
| CY2021Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
0 | USD |
| CY2022Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
|
3479250 | USD |
| CY2021Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
|
-6295514 | USD |
| CY2021Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
24747613 | USD |
| CY2020Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
21531665 | USD |
| CY2022Q1 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
28226863 | USD |
| CY2021Q1 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
15236151 | USD |
| CY2022Q1 | us-gaap |
Interest Paid Net
InterestPaidNet
|
0 | USD |
| CY2021Q1 | us-gaap |
Interest Paid Net
InterestPaidNet
|
0 | USD |
| CY2022Q1 | us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
0 | USD |
| CY2021Q1 | us-gaap |
Income Taxes Paid
IncomeTaxesPaid
|
0 | USD |
| CY2022Q1 | ltbr |
Accumulated Preferred Stock Dividend
AccumulatedPreferredStockDividend
|
0 | USD |
| CY2021Q1 | ltbr |
Accumulated Preferred Stock Dividend
AccumulatedPreferredStockDividend
|
188923 | USD |
| CY2022Q1 | ltbr |
Payment Of Accrued Liabilities With Common Stock
PaymentOfAccruedLiabilitiesWithCommonStock
|
15000 | USD |
| CY2021Q1 | ltbr |
Payment Of Accrued Liabilities With Common Stock
PaymentOfAccruedLiabilitiesWithCommonStock
|
69690 | USD |
| CY2020Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
17207557 | USD |
| CY2021Q1 | us-gaap |
Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
|
69690 | USD |
| CY2021Q1 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
60068 | USD |
| CY2021Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-2011988 | USD |
| CY2021Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
24791127 | USD |
| CY2022Q1 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
264936 | USD |
| CY2022Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-2049529 | USD |
| CY2022Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
28434397 | USD |
| CY2022Q1 | us-gaap |
Cash
Cash
|
28200000 | USD |
| CY2022Q1 | ltbr |
Working Capital Surplus
WorkingCapitalSurplus
|
28300000 | USD |
| CY2022Q1 | ltbr |
Net Cash Used In Operating Activities
NetCashUsedInOperatingActivities
|
1900000 | USD |
| CY2022Q1 | us-gaap |
Profit Loss
ProfitLoss
|
-2000000.0 | USD |
| CY2021Q1 | us-gaap |
Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
|
75000000 | USD |
| CY2021Q4 | us-gaap |
Deposits
Deposits
|
15700000 | USD |
| CY2022Q1 | us-gaap |
Cash Fdic Insured Amount
CashFDICInsuredAmount
|
250000 | USD |
| CY2022Q1 | us-gaap |
Interest Income Securities Us Treasury
InterestIncomeSecuritiesUSTreasury
|
9000000.0 | USD |
| CY2022Q1 | us-gaap |
Deposits
Deposits
|
19200000 | USD |
| CY2022Q1 | ltbr |
Contributed Services Research And Development Expenses
ContributedServicesResearchAndDevelopmentExpenses
|
100000 | USD |
| CY2022Q1 | us-gaap |
Indefinite Lived Trademarks
IndefiniteLivedTrademarks
|
100000 | USD |
| CY2022Q1 | ltbr |
Leases
Leases
|
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In accordance with ASU 2016-02, <em>Leases (Topic 842)</em>, which requires recognition of most lease arrangements on the balance sheet, the Company recognizes operating lease right of use assets and liabilities at commencement date based on the present value of the future minimum lease payments over the lease term. Leases with an initial term of 12 months or less are not recorded on the consolidated balance sheet in accordance with the short-term lease recognition exemption. The Company applies the practical expedient to non-separate and non-lease components for all leases that qualify. Lease expense is recognized on a straight-line basis over the lease term. The Company has only one lease for office rent and the lease is for a term of 12 months without renewal options. See Note 4 for additional information. </p> | |
| CY2022Q1 | ltbr |
Common Stock Warrantstspolicytextblock
CommonStockWarrantstspolicytextblock
|
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company accounts for common stock warrants as either equity instruments or derivative liabilities depending on the specific terms of the warrant agreement. Common stock warrants are accounted for as a derivative in accordance with ASC 815, <em>Derivatives and Hedging,</em> if the stock warrants contain terms that could potentially require “net cash settlement” and therefore, do not meet the scope exception for treatment as a derivative. Warrant instruments that could potentially require “net cash settlement” in the absence of explicit language precluding such settlement are initially classified as derivative liabilities at their estimated fair values, regardless of the likelihood that such instruments will ever be settled in cash.</p> | |
| CY2022Q1 | ltbr |
Net Loss Attributable To Common Stockholders
NetLossAttributableToCommonStockholders
|
-2000000.0 | USD |
| CY2021Q1 | ltbr |
Net Loss Attributable To Common Stockholders
NetLossAttributableToCommonStockholders
|
-2200000 | USD |
| CY2022Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
10283280 | shares |
| CY2021Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
6589392 | shares |
| CY2022Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.20 | |
| CY2021Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
-0.33 | |
| CY2022Q1 | us-gaap |
Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
|
-2000000.0 | USD |
| CY2021Q1 | us-gaap |
Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
|
-2200000 | USD |
| CY2022Q1 | ltbr |
Net Loss Diluted
NetLossDiluted
|
-2000000.0 | USD |
| CY2021Q1 | ltbr |
Net Loss Diluted
NetLossDiluted
|
-2200000 | USD |
| CY2022Q1 | ltbr |
Weighted Average Common Shares Outstanding
WeightedAverageCommonSharesOutstanding
|
10283280 | shares |
| CY2021Q1 | ltbr |
Weighted Average Common Shares Outstanding
WeightedAverageCommonSharesOutstanding
|
6589392 | shares |
| CY2022Q1 | ltbr |
Potential Common Share Issuancesabstract
PotentialCommonShareIssuancesabstract
|
10283280 | USD |
| CY2021Q1 | ltbr |
Potential Common Share Issuancesabstract
PotentialCommonShareIssuancesabstract
|
6589392 | USD |
| CY2022Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.20 | |
| CY2021Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
-0.33 | |
| CY2022Q1 | ltbr |
Warrants Outstanding
WarrantsOutstanding
|
45577 | shares |
| CY2021Q1 | ltbr |
Warrants Outstanding
WarrantsOutstanding
|
59242 | shares |
| CY2022Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Period Increase Decrease
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease
|
543297 | shares |
| CY2021Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Period Increase Decrease
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease
|
515136 | shares |
| CY2022Q1 | ltbr |
Rsas Outstanding
RsasOutstanding
|
188588 | USD |
| CY2021Q1 | ltbr |
Rsus Outstanding
RsusOutstanding
|
243800 | USD |
| CY2021Q1 | ltbr |
Series A Convertible Preferred Stock To Common Shares
SeriesAConvertiblePreferredStockToCommonShares
|
80712 | shares |
| CY2021Q1 | ltbr |
Series B Convertible Preferred Stock To Common Shares
SeriesBConvertiblePreferredStockToCommonShares
|
276846 | USD |
| CY2022Q1 | us-gaap |
Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
|
777462 | shares |
| CY2021Q1 | us-gaap |
Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
|
1175736 | shares |
| CY2021Q4 | us-gaap |
Accounts Payable Trade Current And Noncurrent
AccountsPayableTradeCurrentAndNoncurrent
|
100000 | USD |
| CY2022Q1 | us-gaap |
Accounts Payable Trade Current And Noncurrent
AccountsPayableTradeCurrentAndNoncurrent
|
100000 | USD |
| CY2021Q4 | us-gaap |
Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
|
100000 | USD |
| CY2022Q1 | us-gaap |
Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
|
100000 | USD |
| CY2022Q1 | ltbr |
Accrued Bonuses
AccruedBonuses
|
300000 | USD |
| CY2022Q1 | us-gaap |
Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
|
500000 | USD |
| CY2021Q4 | us-gaap |
Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
|
200000 | USD |
| CY2022Q1 | ltbr |
Operating Lease Term
OperatingLeaseTerm
|
P12Y | |
| CY2022Q1 | ltbr |
Operating Lease Monthly Payment
OperatingLeaseMonthlyPayment
|
8000 | USD |
| CY2022Q1 | us-gaap |
Operating Lease Payments Use
OperatingLeasePaymentsUse
|
100000 | USD |
| CY2022Q1 | us-gaap |
Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
|
24000 | USD |
| CY2021Q1 | us-gaap |
Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
|
30000 | USD |
| CY2021Q4 | ltbr |
Stock Options Outstanding
StockOptionsOutstanding
|
10532101 | shares |
| CY2019Q4 | ltbr |
Total Project Value
TotalProjectValue
|
500000 | USD |
| CY2021 | ltbr |
Contributed Services Research And Development Expenses
ContributedServicesResearchAndDevelopmentExpenses
|
100000 | USD |
| CY2021Q1 | ltbr |
Total Project Value
TotalProjectValue
|
700000 | USD |
| CY2022Q1 | ltbr |
Contributed Services Research And Development Expenses
ContributedServicesResearchAndDevelopmentExpenses
|
100000 | USD |
| CY2021Q1 | ltbr |
Contributed Services Research And Development Expenses
ContributedServicesResearchAndDevelopmentExpenses
|
0 | USD |
| CY2022Q1 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
10588674 | shares |
| CY2022Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
|
188588 | shares |
| CY2022Q1 | us-gaap |
Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
|
45577 | shares |
| CY2022Q1 | ltbr |
Convertible Restricted Stock
ConvertibleRestrictedStock
|
188588 | shares |
| CY2022Q1 | ltbr |
Stock Options Outstanding
StockOptionsOutstanding
|
11366136 | shares |
| CY2021Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
9759223 | shares |
| CY2021Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
|
188588 | shares |
| CY2021Q4 | us-gaap |
Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
|
45577 | shares |
| CY2021Q4 | ltbr |
Convertible Restricted Stock
ConvertibleRestrictedStock
|
188588 | shares |
| CY2022Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
|
1.1537 | pure |
| CY2022Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
|
0.0102 | pure |
| CY2022Q1 | us-gaap |
Other Interest And Dividend Income
OtherInterestAndDividendIncome
|
0 | USD |
| CY2022Q1 | us-gaap |
Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
|
P2Y | |
| CY2022Q1 | us-gaap |
Share Price
SharePrice
|
6.27 | |
| CY2021Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
538713 | shares |
| CY2022Q1 | ltbr |
Weighted Average Exercise Price Beginning
WeightedAverageExercisePriceBeginning
|
18.51 | |
| CY2021Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
|
12.92 | |
| CY2022Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
|
13514 | shares |
| CY2022Q1 | ltbr |
Weighted Average Exercise Price Stock Options Granted
WeightedAverageExercisePriceStockOptionsGranted
|
6.27 | |
| CY2022Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
|
3.70 | |
| CY2022Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
|
8930 | shares |
| CY2022Q1 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
|
8.25 | |
| CY2022Q1 | ltbr |
Weighted Average Fair Value Stock Options Expired
WeightedAverageFairValueStockOptionsExpired
|
2.80 | |
| CY2022Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
543297 | shares |
| CY2022Q1 | ltbr |
Weighted Average Exercise Price End
WeightedAverageExercisePriceEnd
|
18.37 | |
| CY2022Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
|
12.86 | |
| CY2022Q1 | ltbr |
Options Outstanding Options Exercisable
OptionsOutstandingOptionsExercisable
|
531531 | shares |
| CY2022Q1 | ltbr |
Weighted Average Exercise Price Options Exercisable
WeightedAverageExercisePriceOptionsExercisable
|
18.65 | |
| CY2022Q1 | ltbr |
Weighted Average Fair Value Options Exercisable
WeightedAverageFairValueOptionsExercisable
|
13.05 | |
| CY2022Q1 | ltbr |
Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm
|
P5Y | |
| CY2022Q1 | ltbr |
Number Of Awards Stock Option Outstanding
NumberOfAwardsStockOptionOutstanding
|
543297 | shares |
| CY2022Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
|
18.37 | |
| CY2022Q1 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
|
P4Y11M1D | |
| CY2022Q1 | ltbr |
Number Of Awards Stock Options Vested
NumberOfAwardsStockOptionsVested
|
531531 | shares |
| CY2022Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
|
18.65 | |
| CY2022Q1 | ltbr |
Schedule Of Fair Value Of Options
ScheduleOfFairValueOfOptions
|
<table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="14" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Year Ending December 31,</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2022</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2023</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2024</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Total</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Scheduled vesting</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">62,862</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">62,864</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">62,862</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;">188,588</td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table> |
